Expert Opinion on Drug Safety

Reassessing the safety of intravenous and compounded injectable colchicine in acute gout treatment
pp. 625-629(5)
Author: Schlesinger, Naomi

The safety of amodiaquine use in pregnant women
pp. 631-635(5)
Authors: Tagbor, Harry K; Chandramohan, Daniel; Greenwood, Brian

Toxicities of topical ophthalmic anesthetics
pp. 637-640(4)
Authors: McGee, Hall T; Fraunfelder, FW

Sleep-disordered breathing with chronic opioid use
pp. 641-649(9)
Authors: Teichtahl, Harry; Wang, David

The pharmacology and safety of paliperidone extended-release in the treatment of schizophrenia
pp. 651-662(12)
Authors: Spina, Edoardo; Cavallaro, Roberto

Renal safety of intravenous bisphosphonates in the treatment of osteoporosis
pp. 663-672(10)
Authors: Lewiecki, E Michael; Miller, Paul D

Idiosyncratic drug-induced liver injury: an overview
pp. 673-684(12)
Authors: Hussaini, S Hyder; Farrington, Elizabeth A

The safety of drugs for the treatment of nausea and vomiting of pregnancy
pp. 685-694(10)
Authors: Gill, Simerpal K; Einarson, Adrienne

Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable
pp. 695-704(10)
Authors: Salazar, Joel A; Poon, Ivy; Nair, Mridula

Effect of consumer reporting on signal detection: using disproportionality analysis
pp. 705-712(8)
Authors: Hammond, Isaac W; Rich, Donna S; Gibbs, Trevor G

Database size and power to detect safety signals in pharmacovigilance
pp. 713-721(9)
Authors: Hammond, Isaac W; Gibbs, Trevor G; Seifert, Harry A; Rich, Donna S